<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><description>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 09 Mar 2021 07:36:25 +0800</pubDate><image><url>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</url><title>小药说药 | wechat-feeds</title><link>http://MzAxMDMyMTQwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>小药谈ADC：第三代ADC</title><link>https://mp.weixin.qq.com/s/W0OuHVyA1Q23W0SMzHZpzw</link><description></description><content:encoded><![CDATA[小药谈ADC：第三代ADC]]></content:encoded><pubDate>Tue, 09 Mar 2021 06:06:38 +0800</pubDate></item><item><title>小药谈ADC: ADC的盛世华年</title><link>https://mp.weixin.qq.com/s/r1zWNcrTuTBN_CSaq2jmgA</link><description></description><content:encoded><![CDATA[小药谈ADC: ADC的盛世华年]]></content:encoded><pubDate>Tue, 09 Mar 2021 06:06:38 +0800</pubDate></item><item><title>小药谈ADC：ADC的免疫原性</title><link>https://mp.weixin.qq.com/s/wbRHkqAt6bsp7SKWAWw26A</link><description></description><content:encoded><![CDATA[小药谈ADC：ADC的免疫原性]]></content:encoded><pubDate>Tue, 09 Mar 2021 06:06:38 +0800</pubDate></item><item><title>小药综述：精准医学的关键差距与机遇</title><link>https://mp.weixin.qq.com/s/j-8LnDLGNCBbwbX7tgjXpw</link><description></description><content:encoded><![CDATA[小药综述：精准医学的关键差距与机遇]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：肿瘤免疫治疗当前的趋势转变</title><link>https://mp.weixin.qq.com/s/M_vNa-kVZO7_9w9HGFDe5Q</link><description></description><content:encoded><![CDATA[小药综述：肿瘤免疫治疗当前的趋势转变]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：靶向抗癌药物的免疫调节作用</title><link>https://mp.weixin.qq.com/s/8DyfqLtKcqpc74SO7S_jOA</link><description></description><content:encoded><![CDATA[小药综述：靶向抗癌药物的免疫调节作用]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：肿瘤代谢重编程与免疫应答</title><link>https://mp.weixin.qq.com/s/3qN64IamxAAmQpNDH4qG3g</link><description></description><content:encoded><![CDATA[小药综述：肿瘤代谢重编程与免疫应答]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：自身免疫疾病</title><link>https://mp.weixin.qq.com/s/tCKwx59RWdCN1VdB8JsnDw</link><description></description><content:encoded><![CDATA[小药综述：自身免疫疾病]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：人工智能与药物研发</title><link>https://mp.weixin.qq.com/s/RWgtYRIcnhdoXCIWZNwopw</link><description></description><content:encoded><![CDATA[小药综述：人工智能与药物研发]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：COVID-19下火热的IO药物</title><link>https://mp.weixin.qq.com/s/h3Oo283ldZs0XR2jZI-s4A</link><description></description><content:encoded><![CDATA[小药综述：COVID-19下火热的IO药物]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药综述：肿瘤免疫中的小分子药物</title><link>https://mp.weixin.qq.com/s/msr63ZetfP-rplqJvf_94Q</link><description></description><content:encoded><![CDATA[小药综述：肿瘤免疫中的小分子药物]]></content:encoded><pubDate>Mon, 08 Mar 2021 06:11:07 +0800</pubDate></item><item><title>小药谈双抗：挑战与开发策略</title><link>https://mp.weixin.qq.com/s/N0bYFNKxX57JNGwEzG57gg</link><description></description><content:encoded><![CDATA[小药谈双抗：挑战与开发策略]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗：结构与功能优化</title><link>https://mp.weixin.qq.com/s/chE784-qcvyZzsnjUr3g6Q</link><description></description><content:encoded><![CDATA[小药谈双抗：结构与功能优化]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗：BiTEs和它的兄弟姐妹</title><link>https://mp.weixin.qq.com/s/bGRa-ueVuVZWoFBkbPMAAQ</link><description></description><content:encoded><![CDATA[小药谈双抗：BiTEs和它的兄弟姐妹]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗：CD33靶向双抗</title><link>https://mp.weixin.qq.com/s/CRvviuBQRs1T69sXzyeLjg</link><description></description><content:encoded><![CDATA[小药谈双抗：CD33靶向双抗]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈双抗: 阿斯利康PD-1/CTLA-4双抗</title><link>https://mp.weixin.qq.com/s/Wl7gZ6NaOH0CsX7C1lldUg</link><description></description><content:encoded><![CDATA[小药谈双抗: 阿斯利康PD-1/CTLA-4双抗]]></content:encoded><pubDate>Sun, 07 Mar 2021 06:14:09 +0800</pubDate></item><item><title>小药谈TME：Sialoglycans和Siglecs</title><link>https://mp.weixin.qq.com/s/PQbzn6zlldg4C2fOoi1e8Q</link><description></description><content:encoded><![CDATA[小药谈TME：Sialoglycans和Siglecs]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：TGF-β</title><link>https://mp.weixin.qq.com/s/YJbCspyPmv5CmUzBpwPzVA</link><description></description><content:encoded><![CDATA[小药谈TME：TGF-β]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：EZH2</title><link>https://mp.weixin.qq.com/s/0WC6Jq11D3g4Pq93NXaPUQ</link><description></description><content:encoded><![CDATA[小药谈TME：EZH2]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item><item><title>小药谈TME：Treg</title><link>https://mp.weixin.qq.com/s/N_AW3zqcFS6zarhv1NSH6A</link><description></description><content:encoded><![CDATA[小药谈TME：Treg]]></content:encoded><pubDate>Sat, 06 Mar 2021 06:05:15 +0800</pubDate></item></channel></rss>